Vivo Capital, LLC Relmada Therapeutics, Inc. Transaction History

Vivo Capital, LLC

  • $683 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$18.3 - $37.02 $134,614 - $272,319
7,356 Added 1.04%
713,238 $26.4 Million
Q1 2022

May 13, 2022
SELL
$16.72 - $26.99 $2.95 Million - $4.76 Million
-176,470 Reduced 20.0%
705,882 $19.1 Million
Q4 2021

Feb 11, 2022
BUY
$16.93 - $26.82 $14.9 Million - $23.7 Million
882,352 New
882,352 $19.9 Million

Others Institutions Holding RLMD

# of Institutions
80
Shares Held
12.3M
Call Options Held
229K
Put Options Held
138K
View Full List

About RELMADA THERAPEUTICS, INC.

RLMD Quotes by TradingView
  • Ticker RLMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,608,500
  • Market Cap $11.7M
  • Description
  • Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...
More about RLMD
Track This Portfolio

Track Vivo Capital, LLC Portfolio

Follow Vivo Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vivo Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email